Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Posters
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Posters
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Subscribe!
Subscribe Today!
TRI
This person does not yet have a bio.
Content by TRI
| 5 min read
by
Dr. Steven R. Smith
and
TRI
Paradigm shift: Rethinking type 2 diabetes as a heterogeneous disease
The only way we will see true, long-term success in treating diabetes is by fundamentally rethinking this disease and shifting our focus to pursue a targeted, personalized approach to prevention, diagnosis and treatment.
Articles
Page 1 of 1 - 1 Total Items
1
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Webinars
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Articles
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
Compendium
Latest Issue
Volume 21 • Issue 1 • March 2025
March 2025
March 2025 Issue
Explore this issue